ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Na, Seong K. | - |
dc.contributor.author | Yim, Sun Y. | - |
dc.contributor.author | Suh, Sang J. | - |
dc.contributor.author | Jung, Young K. | - |
dc.contributor.author | Kim, Ji H. | - |
dc.contributor.author | Seo, Yeon S. | - |
dc.contributor.author | Yim, Hyung J. | - |
dc.contributor.author | Yeon, Jong E. | - |
dc.contributor.author | Byun, Kwan S. | - |
dc.contributor.author | Um, Soon H. | - |
dc.date.available | 2020-11-02T07:41:27Z | - |
dc.date.issued | 2018-04 | - |
dc.identifier.issn | 0022-4790 | - |
dc.identifier.issn | 1096-9098 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/3663 | - |
dc.description.abstract | Background The prognostic performance of the albumin-bilirubin (ALBI) grade in hepatocellular carcinoma (HCC) as an objective method of assessing liver function was investigated. Methods Data from 2099 patients with HCC in Korea were collected and analyzed retrospectively. The discriminative performance of ALBI grade was compared with Child-Pugh (C-P) grade for different stages or treatments. Results The median follow up duration was 16.2 months (range: 1.0-124.9). The median survival times were 49.7 months for C-P grade A (65.8%), 12.4 months for C-P grade B (25.5%), and 4.2 months for C-P grade C (8.6%) (P < 0.001). The median survival times were 84.2 months for ALBI grade 1 (32.8%), 25.5 months for ALBI grade 2 (53.5%), and 7.7 months for ALBI grade 3 (13.7%) (P < 0.001). In early UICC stages, ALBI grade showed better discriminative performance than C-P grade. In curative treatments, ALBI grade also showed better discriminative performance than C-P grade (Harrell's C: 0.624 (C-P grade) vs 0.667 [ALBI grade]). Conclusions ALBI grade provided better prognostic performance in survival analysis and better distribution of the grades than C-P grade in HCC, suggesting that ALBI grade could be a good alternative grading system for liver function in patients with HCC. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | John Wiley & Sons Inc. | - |
dc.title | ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1002/jso.24992 | - |
dc.identifier.scopusid | 2-s2.0-85047834494 | - |
dc.identifier.wosid | 000434145500013 | - |
dc.identifier.bibliographicCitation | Journal of Surgical Oncology, v.117, no.5, pp 912 - 921 | - |
dc.citation.title | Journal of Surgical Oncology | - |
dc.citation.volume | 117 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 912 | - |
dc.citation.endPage | 921 | - |
dc.type.docType | Article; Proceedings Paper | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | ALBUMIN-BILIRUBIN | - |
dc.subject.keywordPlus | SORAFENIB | - |
dc.subject.keywordPlus | PROGNOSIS | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | CIRRHOSIS | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | SCORES | - |
dc.subject.keywordAuthor | ALBI grade | - |
dc.subject.keywordAuthor | Child-Pugh grade | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | prognosis | - |
dc.subject.keywordAuthor | survival | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.